Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

American Century Equity Income Fund's investment thesis on Johnson & Johnson ($JNJ) — Q4 2025 | Buyside Digest

All Pitches

View Letter Analysis

$JNJJohnson & Johnson

BULL

American Century Equity Income Fund

Fund Letter

Q4 2025

Published December 31, 2025

View Fund Profile

$285.75USD

Current Market Price

Market Cap$619.2B

Pitch Price$207.35

Technical Chart

From the Fund Letter

Reported better-than-expected earnings and announced it would spin off its orthopedics segment. Earlier drug pricing...

— Brian Woglom, Paul Howanitz, Kevin Toney

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.

Institutional Pitch Library

Proprietary AI Analysis

100 Letter Unlocks/Quarter

SUBSCRIBE TO BSD RESEARCH Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $JNJ, and what else American Century Equity Income Fund is buying.

Other pitches on $JNJ

Other investors who've written on Johnson & Johnson

Seeking Alpha ContributorNEUTRAL

Pitched Aug 16, 2026•Pitched at $260.35

Johnson & Johnson has shown strong performance in 2026, with shares up 28% total return, outperforming the S&P 500 and the Health Care Sector ETF. Despite ...

View all $JNJ pitches →